You are here

Article Text

Article menu
Download PDFPDF
Education in Heart
Clinical Pharmacology
Fallacies in clinical cardiovascular trials

https://doi.org/10.1136/hrt.2008.154542

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Footnotes

    • Competing interests In compliance with EBAC/EACCME guidelines, all authors participating in Education in Heart have disclosed potential conflicts of interest that might cause a bias in the article. The author has received research support from Astrazeneca, Amgen, Novartis, Servier and MSD, and has received honoraria for lectures/advisory board from Astrazeneca, Amgen, BMS, Novartis, Otsuka, Pfizer, Servier and MSD.

    • Additional references are published online only athttp://heart.bmj.com/content/vol95/issue17